Labs Articles

The Evolution of Imaging Techniques in Clinical Trials

Apr 01, 2015

By Ashwin Shetty, MD

Evaluating the use of new tumor measurement tools for studies of molecular-targeted cancer therapies.

The Future of QT in Clinical Trials

Sep 22, 2014

By Timothy Callahan, PhD

The US FDA, in open meetings, stated the Thorough QT trial "must" be replaced.

Circulating Tumor Cell Testing

Mar 01, 2013

By Chengsen Xue, Carla G. Hill, Thomas W. Mc Closkey

A CTC test may fulfill an unmet need in oncology clinical trials and disease management practices.

Art & Science of Imaging Analytics

Mar 01, 2013

By Amit Vasanji, Brett A. Hoover

Incorporating imaging analytics can improve the quality of work and minimize unexpected delays.

Labs News

INC Research Receives iCardiac Site Certification

With this technology in place, INC may be able to eliminate the need for a separate, dedicated Thorough QT (TQT) studies.

INTERLAB Changes Name

INTERLAB and synlab have been successfully cooperating since 2004.

Pharma Invests in Companion Diagnostics

Tufts CSDD finds drug and diagnostics companies are investing in the development of companion diagnostics that can show that their use in conjunction with personalized therapeutics will lead to positive health outcomes.

New Consensus Recommendations Announced for Standardized Imaging Protocol

The Jumpstarting Brain Tumor Drug Development Coalition (JBTDDC) announced a new consensus protocol for magnetic resonance imaging (MRI) in brain tumor clinical trials to help assess if a new treatment is effective.

iCardiac Acquires nSpire Health’s Clinical Trials Division

Applied Clinical Trials discusses acquisition with iCardiac CEO Alex Zapesochny.